Stomach Cancer Clinical Trial
Official title:
The Effect of Mosapride Citrate on Gastrointestinal Motility After Gastrectomy:
"Mosapride citrate is a 5-hydroxytryptamine 4 receptor agonist, and is widely used as an
agent to increase intestinal motility. Mosapride citrate has been demonstrated in in vitro
and in vivo studies to increase both gastric and colon motility. In a case-control study of
patients undergoing colonectomy, mosapride citrate was found to significantly reduce gas
passing and defecation time.
Recently, a study reported that mosapride citrate acts on the α7nACh receptor and,
consequently, suppresses the inflammatory response of macrophages, thereby suppressing the
mechanism that induces paralysis after surgery.
To date, this study is intended to analyze whether mosapride citrate significantly affects
the improvement of bowel movement after surgery after gastrectomy."
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03384511 -
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.
|
Phase 4 | |
| Completed |
NCT03652077 -
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
|
Phase 1 | |
| Completed |
NCT02604979 -
The Influences of Long Periods of Pneumoperitoneum and Head up Position on the Variation of Heart-rate Corrected QT Interval During Robotic-assisted Laparoscopic Gastrectomy - Observational Study
|
N/A | |
| Active, not recruiting |
NCT00394433 -
Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
|
Phase 2 | |
| Completed |
NCT00201747 -
Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer
|
Phase 2 | |
| Completed |
NCT00215514 -
Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma
|
Phase 0 | |
| Recruiting |
NCT04486651 -
HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer
|
Phase 3 | |
| Recruiting |
NCT05415475 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT04526470 -
Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT01257711 -
A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer
|
N/A | |
| Recruiting |
NCT04907643 -
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
|
N/A | |
| Withdrawn |
NCT03704077 -
An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
|
Phase 2 | |
| Recruiting |
NCT05489250 -
The PLATON Network
|
||
| Recruiting |
NCT04484636 -
PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)
|
N/A | |
| Completed |
NCT02547064 -
Effect of Modified Stylet Angulation on the Intubation With GlideScope®
|
N/A | |
| Withdrawn |
NCT00800969 -
Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and Stomach
|
Phase 2 | |
| Completed |
NCT00296322 -
Trial of Adjuvant Chemotherapy for Gastric Cancer
|
Phase 3 | |
| Recruiting |
NCT04215861 -
Clinical Study on Raman Spectra of Blood, Saliva and Urine in Patients With Cancer Treated by Modern Therapy
|
||
| Recruiting |
NCT06199895 -
Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer
|
Phase 2 | |
| Recruiting |
NCT01038154 -
Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal Cancer
|
Phase 4 |